Holoclara

Holoclara is the first biotechnology company to create a safe, orally administered worm-derived therapy aimed at providing relief for millions of patients with allergies and autoimmune diseases. Founded and led by physician-scientist Andrea Choe, Holoclara harnesses potent immunomodulatory molecules from intestinal roundworms, building on decades of preclinical data demonstrating their therapeutic efficacy across multiple diseases. With a team of world-renowned experts in helminth biology and biotechnology, and supported by leading life science and technology investors, Holoclara is uniquely positioned to leverage the therapeutic potential of worms to address historically incurable diseases.